Biolattice

Biolattice is positioning itself as a key enabler in the advanced biofabrication space by offering a fully integrated, closed-loop platform combining sophisticated hardware (BioLoom printer) with intelligent, no-code software (Loominus Studio). The company's mission is to democratize the creation of complex 3D biological structures, such as tissues and medical devices, by automating and simplifying the entire workflow from design to fabrication. Its solutions target both academic researchers and commercial developers, emphasizing reproducibility, customization, and accelerated commercialization. By leveraging AI and machine learning for real-time monitoring and adaptive process control, BLI aims to reduce technical barriers and drive breakthroughs in regenerative medicine.

Integrated hardware-software platform for intelligent 3D biofabrication, comprising the BioLoom (multi-tool 3D bioprinter with sterility control) and Loominus Studio (no-code, AI-driven software for creating and managing closed-loop biofabrication workflows).

Competes in the 3D bioprinting market against established players like CELLINK (BICO) and Allevi, as well as numerous academic spinoffs and startups. Differentiation is based on its fully integrated, multi-tool hardware platform combined with a proprietary, AI-driven software suite for end-to-end workflow automation and control.